​Intarcia gets another $206M and announces a new disease target: HIV – Boston Business Journal

January 03 13:55 2017

Boston-based Intarcia Therapeutics said today that it's nabbed another $206 million in financing as it awaits FDA approval of its diabetes drug-and-device combination, and is also partnering with the Bill & Melinda Gates Foundation in a whole new field …

Read Full Story On bizjournals.com